NCT06411353Recruiting
Blood Flow Conditions and Sounds in AVFs
The Relationship Between Blood Flow Conditions and Sounds in Arteriovenous Fistulae for Hemodialysis
Source: ClinicalTrials.gov · Last updated 4 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a prospective non-pharmacological interventional study aimed at investigating the relationship between the blood flow condition and the arteriovenous fistula (AVF) sound, with the ultimate aim of predicting the AVF clinical, in patients with end-stage renal disease (ESRD) who require the creation of a vascular access for extracorporeal circulation.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 8 May 2024
- Start date
- 1 Mar 2025
- Primary completion date
- Feb 2028
- Lead sponsor
- Mario Negri Institute for Pharmacological Research
- Diseases
- Chronic kidney disease
- NCT number
- NCT06411353
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 1 Mar 2025 to the primary completion date, Feb 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of a previously failed AVF in the same arm selected for surgery.
Other illness
- Patients with contraindications to MRI including: pregnancy, claustrophobia, cardiac pacemakers or other MRI-incompatible prostheses.
Other
- Contraindications for the creation of an autogenous AVF.
- Patients already on HD treatment through a catheter or a graft.
- Patients undergoing peritoneal dialysis.
- Patients with a life expectancy of less than 2 years.
Who the study is looking for
- Provision of informed consent prior to any study specific procedures.
- Female and/or male aged between 18 and 90 years.
- Patients in HD treatment who need a new VA or patients who entered the pre-dialysis program because of ESRD. In all cases, the first-choice treatment is the surgical creation of an autogenous AVF in patient's forearm.
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| A.O. Papa Giovanni XXIII - U.O. Nefrologia e Dialisi Coordinator of this site? Confirm its status | Bergamo | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.